v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,461 $ 3,498
Accounts receivable 8,544 5,078
Other current assets 1,768 1,841
Total current assets 11,773 10,417
Property and equipment, net 1,361 790
Operating lease right of use assets 1,613 1,864
Other long-term assets 45 45
Total assets 14,792 13,116
Current liabilities:    
Accounts payable 1,659 1,544
Accrued salary and bonus 2,207 1,969
Other accrued expenses 1,799 2,163
Note payable at fair value, current 4,290 5,100
Current liabilities of discontinued operations 660 660
Total current liabilities 10,615 11,436
Operating lease liabilities, net of current portion 1,183 1,472
Note payable at fair value 4,243
Other long-term liabilities 5,211 4,968
Total liabilities 17,009 22,119
Commitments and contingencies (Note 11)
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 0 and 47,000 shares Series B issued and outstanding, respectively 46,536
Stockholders’ deficit:    
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 and 0 shares Series C issued and outstanding, respectively
Common stock, $.01 par value; 100,000,000 shares authorized; 4,539,663 and 4,447,489 shares issued, respectively; 4,409,323 and 4,351,445 shares outstanding, respectively 406 405
Additional paid-in capital 234,811 188,146
Accumulated deficit (235,380) (242,082)
Treasury stock, at cost (130,340 and 96,044 shares, respectively) (2,054) (2,008)
Total stockholders’ deficit (2,217) (55,539)
Total liabilities and stockholders’ deficit 14,792 (33,420)
Total liabilities, preferred stock and stockholders’ deficit $ 14,792 $ 13,116

Source

PDF HTML
10-K Filing
ZIP XLS HTML
XBRL